PURPOSE: Previous studies have reported that extranodal spread is a prognostic factor in patients with several solid cancers. However, the definition of extranodal spread varies with the reporting investigator and has not been standardized yet. Therefore, we selected several widely used definitions from previous reports and comparatively assessed the clinicopathologic significance of these definitions. METHODS: Extranodal spread in the 103 node-positive patients who had received curative resections for gastric cancer was classified into two groups, viz., (a) capsule rupture, where cancer cells infiltrated into the perinodal fatty tissue beyond the capsule of the involved lymph node, and (b) no capsule rupture, where nests of cancer cells were detected demonstrable in adjacent tissues around the metastatic lymph node without rupture of the capsule. RESULTS: Sixty-five (63.1%) of the 103 patients showed extranodal spread. Of the 65 patients, 50 patients showed the capsule rupture type and 15 showed the no capsule rupture type of extranodal spread. The 5-year survival rate was significantly poorer in the capsule rupture group as compared with that in the no capsule rupture group and extranodal spread-negative group (P < 0.05 and P < 0.01, respectively). In regard to the mode of recurrence, the rate of peritoneal recurrence was significantly higher in the capsule rupture group (P < 0.01). CONCLUSIONS: In the assessment of patients with extranodal spread, it is considered important to classify the patients based on the status of extranodal spread into the capsule rupture group and no capsule rupture group.
PURPOSE: Previous studies have reported that extranodal spread is a prognostic factor in patients with several solid cancers. However, the definition of extranodal spread varies with the reporting investigator and has not been standardized yet. Therefore, we selected several widely used definitions from previous reports and comparatively assessed the clinicopathologic significance of these definitions. METHODS: Extranodal spread in the 103 node-positive patients who had received curative resections for gastric cancer was classified into two groups, viz., (a) capsule rupture, where cancer cells infiltrated into the perinodal fatty tissue beyond the capsule of the involved lymph node, and (b) no capsule rupture, where nests of cancer cells were detected demonstrable in adjacent tissues around the metastatic lymph node without rupture of the capsule. RESULTS: Sixty-five (63.1%) of the 103 patients showed extranodal spread. Of the 65 patients, 50 patients showed the capsule rupture type and 15 showed the no capsule rupture type of extranodal spread. The 5-year survival rate was significantly poorer in the capsule rupture group as compared with that in the no capsule rupture group and extranodal spread-negative group (P < 0.05 and P < 0.01, respectively). In regard to the mode of recurrence, the rate of peritoneal recurrence was significantly higher in the capsule rupture group (P < 0.01). CONCLUSIONS: In the assessment of patients with extranodal spread, it is considered important to classify the patients based on the status of extranodal spread into the capsule rupture group and no capsule rupture group.
Authors: Sjoerd M Lagarde; Fiebo J W ten Kate; Daan J de Boer; Olivier R C Busch; Hugo Obertop; J Jan B van Lanschot Journal: Am J Surg Pathol Date: 2006-02 Impact factor: 6.394
Authors: Won Hyuk Choi; Sungsoo Kim; Jiayun Shen; Jae Ho Cheong; Woo Jin Hyung; Yong Il Kim; Seung Ho Choi; Sung Hoon Noh; Chan Il Park Journal: J Surg Oncol Date: 2007-06-01 Impact factor: 3.454
Authors: J A Bucci; C W Kennedy; J Burn; D J Gillett; H L Carmalt; M J Donnellan; M G Joseph; S C Pendlebury Journal: Breast Date: 2001-06 Impact factor: 4.380
Authors: S Natsugoe; J Mueller; F Kijima; K Aridome; M Shimada; K Shirao; C Kusano; M Baba; H Yoshinaka; T Fukumoto; T Aikou Journal: Br J Cancer Date: 1997 Impact factor: 7.640
Authors: Nicola Veronese; Matteo Fassan; Laura D Wood; Brendon Stubbs; Marco Solmi; Paola Capelli; Antonio Pea; Alessia Nottegar; Giuseppe Sergi; Enzo Manzato; Sara Carraro; Marco Maruzzo; Ivana Cataldo; Fabio Bagante; Mattia Barbareschi; Liang Cheng; Maria Bencivenga; Giovanni de Manzoni; Claudio Luchini Journal: J Gastrointest Surg Date: 2016-07-13 Impact factor: 3.452
Authors: Cristina Graham Martínez; Nikki Knijn; Marcel Verheij; Iris D Nagtegaal; Rachel S van der Post Journal: Histopathology Date: 2019-02-10 Impact factor: 5.087